跳至主要内容
临床试验/NCT02643966
NCT02643966已完成不适用

Assessment of Periodic Screening of Women With Denser Breast Using WBUS and DBT (Also Known as "DBTUST-Dense Breast Tomosynthesis / Ultrasound Screening Trial")

Wendie Berg4 个研究点 分布在 1 个国家目标入组 6,266 人开始时间: 2015年12月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
6,266
试验地点
4
主要终点
Sensitivity (True Positive Rate)

研究概览

简要总结

The purpose of this study is to evaluate the role of technologist-performed whole breast ultrasound for detecting breast cancer in the screening population of women with dense breasts.

详细描述

This is a prospective study designed to evaluate the role of whole breast ultrasound (WBUS) in screening for breast cancer. In particular, there is interest in investigating the value of using WBUS as an adjunct (supplementary imaging) to Digital Breast Tomosynthesis (DBT) based screening of women with dense (heterogeneously or extremely dense) breasts or as a primary screening examination in this group of women. Women scheduled for their routine mammography that includes a DBT exam who agree to participate in the study and sign informed consent will undergo (at the same visit) DBT imaging as part of their clinical exam and whole breast ultrasound (WBUS) each year for three rounds of screening plus one year of follow-up. The DBT images and WBUS will be interpreted independently by two experienced radiologists under standard clinical screening procedures. One radiologist will interpret the DBT and the other radiologist will interpret the WBUS. Using a modified "LOGICAL OR" approach women/subjects may be recalled for further diagnostic work-up (examinations). If a subject is recalled, she will then follow the standard/routine clinical procedures for follow-up and the investigators will verify outcomes. If neither radiologist recalls the subject, then the subject will follow conventional management and the investigators will verify outcome. The findings from the DBT and WBUS examinations, as well as any resulting follow-up, will be collected, recorded and analyzed.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Screening
盲法
None

入排标准

年龄范围
40 Years 至 75 Years(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Women aged 40 to 75 years of age with heterogeneously dense or extremely dense parenchyma by prior digital mammography report (i.e., "dense breasts"), presenting for routine annual mammography with digital breast tomosynthesis.

排除标准

  • Known to be at high risk for breast cancer due to known or suspected pathologic BRCA mutation (i.e. first-degree relative with known mutation) or prior chest radiation therapy before age 30;
  • No mammogram within the prior 3 years;
  • Signs or symptoms of breast disease including lump, bloody or spontaneous clear nipple discharge, eczema of the nipple;
  • Pregnancy or lactation within the prior 6 months;
  • Plan to become pregnant in the next two years, as mammography is not typically performed for screening pregnant women;
  • Breast implants, as assessment of breast density may be problematic;
  • Recent prior breast surgery or breast biopsy or cyst aspiration within the prior 12 months;
  • Prior or current malignancy other than the following: a) Breast cancer at least one year earlier (12 full months have elapsed since the last treatment surgery) with no known distant metastases and no known residual tumor; or b) Basal or squamous cell skin cancer or in situ cervical cancer or stage I thyroid cancer; or c) Other cancer for which the patient has been disease free for ≥ 5 years, with no recurrence of cancer in the last five years and no residual disease detected in the last five years.
  • Screening contrast-enhanced MRI or 99mTc-sestamibi based imaging of the breast(s) within the prior 12 months or planned within the next two years, to avoid contamination of results;
  • Unwilling or unable to provide consent.

结局指标

主要结局

Sensitivity (True Positive Rate)

时间窗: 3 years

DBT true positive findings for first observer (usual care) vs DBT and WBUS true positive findings for first observer

Cancer Yield Per 1,000

时间窗: 3 Years

Results from the first radiologist observer are presented

False-positive Recall Rate

时间窗: 3 years

DBT false-positive findings for first observer (usual care) vs DBT and WBUS false positive findings for first observer

次要结局

  • Types of Abnormalities Detected by Ultrasound and Tomosynthesis(3 years)

研究者

发起方
Wendie Berg
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Wendie Berg

Professor of Radiology

University of Pittsburgh

研究点 (4)

Loading locations...

相似试验